-
Understanding the Role of Bilingualism in Cognitive Reserve/Resilience in Aging and AD/ADRD (R01 Clinical Trial Optional)
(RFA-AG-23-001)
National Institute on Aging
Application Receipt Date(s): March 3, 2022
-
Cell-Specific Impact of Liquid-Liquid Phase Separation in Aging and AD/ADRD (R21 Clinical Trial Not Allowed)
(RFA-AG-23-002)
National Institute on Aging
Application Receipt Date(s): March 3, 2022
-
Limited Competition: NIH Health Care Systems Research Collaboratory - Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-AT-22-002)
National Center for Complementary and Integrative Health
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute of Nursing Research
Office of Behavioral and Social Sciences Research
Office of Disease Prevention
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): December 15, 2021
-
HEAL Initiative: Pragmatic and Implementation Studies for the Management of Sickle Cell Disease Pain (UG3/UH3, Clinical Trials Optional)
(RFA-AT-22-004)
National Center for Complementary and Integrative Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Eye Institute
National Heart, Lung, and Blood Institute
National Institute of Nursing Research
Office of Research on Women's Health
Office of Behavioral and Social Sciences Research
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): December 15, 2021
-
HEAL Initiative: Sickle Cell Disease Pain Management Trials Utilizing the Pain Management Effectiveness Research Network Cooperative Agreement (UG3/UH3, Clinical Trial Required)
(RFA-AT-22-005)
National Center for Complementary and Integrative Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Eye Institute
National Heart, Lung, and Blood Institute
National Institute of Nursing Research
National Center for Advancing Translational Sciences
Office of Research on Women's Health
Office of Behavioral and Social Sciences Research
National Institute on Minority Health and Health Disparities
National Center for Advancing Translational Sciences
Application Receipt Date(s): December 15, 2021
-
Coordinating Center for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (U24 Clinical Trial Required)
(RFA-CA-21-045)
National Cancer Institute
Application Receipt Date(s): December 28, 2021
-
Research Bases for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required)
(RFA-CA-21-046)
National Cancer Institute
Application Receipt Date(s): December 28, 2021
-
Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required)
(RFA-CA-21-047)
National Cancer Institute
Application Receipt Date(s): December 28, 2021
-
Home and Community-Based Physical Activity Interventions to Improve the Health of Wheelchair Users (R01 Clinical Trial Required)
(RFA-HD-22-017)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): March 30, 2022
-
Elucidating the Role of Nutrition in Care and Development of Preterm Infants (R01 Clinical Trial Optional)
(RFA-HD-22-023)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): March 30, 2022
-
Promoting Reproductive Health for Adolescents and Adults with Disabilities (R01 Clinical Trial Optional)
(RFA-HD-23-005)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Office of Research on Women's Health
Application Receipt Date(s): March 30, 2022
-
Cellular Senescence Network: Murine Tissue Mapping Centers (U54 - Clinical Trial Not Allowed)
(RFA-RM-22-003)
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s): January 19, 2022
-
Cellular Senescence Network: Technology Development and Application in Human Systems (UG3/UH3 Clinical Trial Not Allowed)
(RFA-RM-22-004)
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s): January 18, 2022
-
Cellular Senescence Network: Technology Development and Application in Murine Systems (UG3/UH3 Clinical Trial Not Allowed)
(RFA-RM-22-005)
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s): January 19, 2022